InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,598.54
(
0.39%
)
US TECH 100
19,957.07
(
0.23%
)
Dow Jones
39,371.12
(
0.20%
)
Brent Oil
85.03
(
0.39%
)
Bitcoin
57,829.51
(
-0.33%
)
Post# of 203990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Zorro

Send PM Follow Ignore
Followers 262
Posts 35009
Boards Moderated 3
Alias Born 02/22/2005

Zorro

Re: Kapone post# 24223

Wednesday, 07/12/2006 11:53:29 AM

Wednesday, July 12, 2006 11:53:29 AM

Post# of 203990
Nice post. Thanks. Liked this part:
Dr. Ramesh C Pandey, Chairman and CEO of Xechem said “we are very fortunate to have attracted such a knowledgeable and prestigious group of distinguished professionals and business leaders to help us in marketing NICOSAN™/HEMOXIN™ for the treatment of Sickle Cell Disease. We welcome the new Advisory Board members and are looking forward to the valued assistance we know they will offer us in bringing this extremely important drug into the hands of the millions of people who are suffering from this terrible disease.”

KEY WORD: Marketing


“A fool and his money are soon parted.” ~Thomas Tusser

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up